AW
GSK icon

ACG Wealth’s GSK GSK Stock Holding History

ACG Wealth’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-862
Closed -$47K – 555
2022
Q2 		$47K Buy
+862
New +$47.6K 0.01% 442
2017
Q4 		– Sell
-4,275
Closed -$217K – 343
2017
Q3 		$217K Sell
4,275
-871
-17% -$44.2K 0.04% 247
2017
Q2 		$278K Buy
5,146
+838
+19% +$44.7K 0.05% 245
2017
Q1 		$227K Sell
4,308
-669
-13% -$33.9K 0.04% 246
2016
Q4 		$240K Buy
+4,977
New +$246K 0.05% 201

Other funds holding GSK

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

ACG Wealth's GSK Position: Q3 2022 in Review

ACG Wealth sold out of GSK (GSK) in Q3 2022, closing a stake of 862 shares — an estimated $47K sold.

ACG Wealth first reported a position in GSK in Q4 2016 and held it in 5 quarters. The position peaked at $278K in Q2 2017. 742 funds tracked by Wall St. Rank hold GSK as of Q3 2022.

  • ACG Wealth reported no remaining GSK position as of Q3 2022 after selling out during the quarter.
  • ACG Wealth sold 862 GSK shares in Q3 2022, an estimated $47K.
  • ACG Wealth first reported a position in GSK in Q4 2016 and held it in 5 quarters.
  • ACG Wealth's GSK position peaked at $278K in Q2 2017.
  • 742 funds tracked by Wall St. Rank held GSK as of Q3 2022.

Based on ACG Wealth's 13F filing for Q3 2022, filed 3 Nov 2022.